Prurigo nodularis (PN) is a distinct, often misdiagnosed disorder imposing significant disease burden. Recent research details major advances in diagnostic tools and summarizes emerging targeted therapies, including inhibitors for IL-31 and other pathways. Timely recognition and an expanding arsenal of treatments promise real improvements in quality of life for PN sufferers. To read more Click Here ##Reference## Kwatra SG, Pereira MP, Misery L, Mollanazar NK, Shah P, Wiggins S. Prurigo nodularis: disease burden, clinical features and approach to management.
Br J Dermatol. 2025;193(4):642-652. doi:10.1093/bjd/ljaf213## What is the cornerstone for improving outcomes in prurigo nodularis? a) Early and accurate diagnosis b) Long-term topical corticosteroids c) Broad-spectrum antibiotics d) Surgical excision
